← Back
$MGX All transactions

Metagenomi Therapeutics, Inc.

A

$ Value

$0

Shares

144,000

Price

$0

Filed

Apr 3

Insider

Name

Wapnick Pamela

Title

Chief Financial Officer

CIK

0001995657

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

144,000

Footnotes

These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. | 25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Filing Info

Accession No.

0001193125-26-141867

Form Type

4

Issuer CIK

0001785279

Wapnick Pamela's History

Date Ticker Type Value
2026-04-01 MGX A $0
2026-04-01 MGX A $0
2026-03-05 MGX $3K
2025-12-05 MGX $3K
2025-12-01 MGX A $192K
2025-09-05 MGX $3K
2025-06-06 MGX $3K

Other Insiders at MGX (90d)

Insider Bought Sold Last
Wapnick Pamela
Chief Financial Officer
$3K 2026-04-01
Irish Jian
Chief Executive Officer
$3K 2026-03-05
Irish Jian
See Remarks
2026-04-01
Wein Matthew
See Remarks
$771 2026-04-01